Lario Therapeutics was awarded $2.4M by The Michael J. Fox Foundation and Wellcome to expand its neuronal calcium channel platform across CNS disorders.
Lario Therapeutics is developing first-in-class precision medicines as disease modifying treatments for severe neurological disorders including epileptic conditions and Parkinson’s disease
Lario Therapeutics is developing first-in-class precision medicines as disease modifying treatments for severe neurological disorders including epileptic conditions and Parkinson’s disease.